A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. Mathur M, Barratt J, Chacko B, Chan TM, et al. N Engl J Med 2023 Nov 2. doi: 10.1056/NEJMoa2305635.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mathur M, Barratt J, Chacko B, Chan TM, et al. A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. N Engl J Med 2023 Nov 2. doi: 10.1056/NEJMoa2305635.
PMID: 37916620